FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Actavis BuPROPion Hydrochloride Extended-Release Recall

BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bot…

Actavis Inc · Parsippany, NJ

Risk level
Class III
Reported by FDA
Aug 14, 2013
Recall ID
D-855-2013
Check your lot numberHow we source this data

Summary

Actavis recalled BuPROPion Hydrochloride Extended-Release starting Jul 31, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-855-2013 on Aug 14, 2013. Reason: Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.

Product description

BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217, NDC 67767-142-30, UPC 3 67767-142-30 6.

Lot numbers, UPCs & expiration codes

Lot #: CG2D18A, Exp 06/14

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-855-2013
Classification
Class III
Status
Terminated
Recall initiated
Jul 31, 2013
FDA report date
Aug 14, 2013
Quantity
15,132 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Actavis Inc

Original FDA data

Every field from FDA enforcement report D-855-2013, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
65881
Address
400 Interpace Pkwy
Code information
Lot #: CG2D18A, Exp 06/14
Postal code
07054-1120
Report date
Aug 14, 2013
Product type
Drugs
Recall number
D-855-2013
Classification
Class III
Recalling firm
Actavis Inc
Product quantity
15,132 bottles
Termination date
May 9, 2014
Reason for recall
Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.
Voluntary / mandated
Voluntary: Firm initiated
Product description
BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217, NDC 67767-142-30, UPC 3 67767-142-30 6.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Jul 31, 2013
Initial firm notification
Letter
Center classification date
Aug 8, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-855-2013, published Aug 14, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls